Calamos Advisors’s Globus Medical GMED Stock Holding History

Calamos Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-17,200	Closed	-$409K	–	623
2016 Q1	$409K	Sell	17,200 -9,600	-36%	-$235K	﹤0.01%	564
2015 Q4	$746K	Sell	26,800 -3,100	-10%	-$77.8K	﹤0.01%	554
2015 Q3	$618K	Hold	29,900	–	–	﹤0.01%	575
2015 Q2	$768K	Hold	29,900	–	–	﹤0.01%	561
2015 Q1	$755K	Hold	29,900	–	–	﹤0.01%	557
2014 Q4	$711K	Hold	29,900	–	–	﹤0.01%	569
2014 Q3	$588K	Buy	29,900 +9,600	+47%	+$198K	﹤0.01%	568
2014 Q2	$486K	Buy	20,300 +4,500	+28%	+$109K	﹤0.01%	604
2014 Q1	$420K	Buy	+15,800	New	+$375K	﹤0.01%	602

Other funds holding GMED

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

AAM

Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Calamos Advisors's GMED Position: Q2 2016 in Review

Calamos Advisors sold out of Globus Medical (GMED) in Q2 2016, closing a stake of 17,200 shares — an estimated $409K sold.

Calamos Advisors first reported a position in GMED in Q1 2014 and held it in 9 quarters. The position peaked at $768K in Q2 2015. 209 funds tracked by Wall St. Rank hold GMED as of Q2 2016.

Calamos Advisors reported no remaining Globus Medical position as of Q2 2016 after selling out during the quarter.
Calamos Advisors sold 17,200 Globus Medical shares in Q2 2016, an estimated $409K.
Calamos Advisors first reported a position in Globus Medical in Q1 2014 and held it in 9 quarters.
Calamos Advisors's Globus Medical position peaked at $768K in Q2 2015.
209 funds tracked by Wall St. Rank held Globus Medical as of Q2 2016.

Based on Calamos Advisors's 13F filing for Q2 2016, filed 26 Jul 2016.